HFE hemochromatosis: an overview about therapeutic recommendations
Hematol., Transfus. Cell Ther. (Impr.)
;
44(1): 95-99, Jan.-Mar. 2022. tab
Article
in English
| LILACS
| ID: biblio-1364881
ABSTRACT
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Iron Metabolism Disorders
/
Hemochromatosis
Type of study:
Practice guideline
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2022
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Santa Casa de São Paulo/BR
/
Universidade Federal de São Paulo - UNIFESP/BR
Similar
MEDLINE
...
LILACS
LIS